These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18316578)

  • 1. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.
    Sund M; Hamano Y; Sugimoto H; Sudhakar A; Soubasakos M; Yerramalla U; Benjamin LE; Lawler J; Kieran M; Shah A; Kalluri R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2934-9. PubMed ID: 15710885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED: Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.
    Lee YJ; Karl DL; Maduekwe UN; Rothrock C; Ryeom S; D'Amore PA; Yoon SS
    Cancer Res; 2010 Nov; 70(21):8357-67. PubMed ID: 20978198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the functions of endogenous angiogenesis inhibitors.
    Grant MA; Kalluri R
    Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic activity of endostatin inhibits C6 glioma growth.
    Peroulis I; Jonas N; Saleh M
    Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
    Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
    Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
    Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
    Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETRACTED: Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
    Lee YJ; Koch M; Karl D; Torres-Collado AX; Fernando NT; Rothrock C; Kuruppu D; Ryeom S; Iruela-Arispe ML; Yoon SS
    Cancer Res; 2010 Feb; 70(3):948-56. PubMed ID: 20103648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J; Sarraf-Yazdi S; Zhang X; Cao Y; Dewhirst MW; Kontos CD; Li CY; Clary BM
    J Surg Res; 2006 Mar; 131(1):97-104. PubMed ID: 16242720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
    Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
    Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.
    Scharovsky OG; Binda MM; Rozados VR; Bhagat S; Cher ML; Bonfil RD
    Clin Exp Metastasis; 2004; 21(2):177-83. PubMed ID: 15168735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.
    Hamano Y; Sugimoto H; Soubasakos MA; Kieran M; Olsen BR; Lawler J; Sudhakar A; Kalluri R
    Cancer Res; 2004 Mar; 64(5):1570-4. PubMed ID: 14996710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
    Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1.
    Zhou L; Isenberg JS; Cao Z; Roberts DD
    Oncogene; 2006 Jan; 25(4):536-45. PubMed ID: 16247480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin-mediated concomitant resistance in neuroblastoma.
    Streck C; Zhang Y; Zhou J; Ng CY; Davidoff A
    J Pediatr Surg; 2004 Mar; 39(3):405-11; discussion 405-11. PubMed ID: 15017561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.